biomarkers

The TREM2 receptor may hold the keys to understanding how myeloid cells affect immune responses to neurological disorders and cancer.

The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom.

Proteomic analysis provides scientists with a deeper understanding of the molecular events that influence health and disease.

Discover how a precise, high-throughput proteomics assay enables researchers to uncover previously unidentified biomarkers.

Discover how automation increases the efficiency and reliability of blood-based liquid biopsy assays.

Scientists advance Parkinson’s disease biomarker research one sniff at a time.

Discovered 30 years ago, microRNAs are increasingly recognized as important regulators of cell physiology and human disease.

First-void urine has emerged as a promising sample type for cancer diagnostic test development.

A new protein sequencing technology paves the way for a better understanding of protein function.

Sequencing advances deliver comprehensive insights into how genomic variation drives cancer initiation and progression.

Researchers investigate tauopathy mechanisms and turn to tau detection methods to help improve health care outcomes and lower the economic burden of these diseases.

Immunoassays help researchers across a range of applications from screening to targeted analysis.

The emergence of innovative analytical methods empowers researchers to comprehensively characterize tumor samples.

Take a deep dive into the latest advances for gathering, integrating, and leveraging multiomics data for biomarker discovery.

Spectral flow cytometry collects the full emission spectrum of a fluorochrome, enabling multicolor panels with more parameters than conventional flow cytometry.

Scientists identify potential microRNA-based diagnostic and predictive biomarkers of neonatal encephalopathy.

Advances in molecular profiling tools and techniques help scientists detect and identify extracellular vesicle markers.

Rare genetic diseases are difficult to diagnose and characterize in the laboratory because of their heterogeneity and global scarcity.

Digital PCR is highly sensitive and precise, making it ideal for detecting rare targets and measuring small-fold changes.